{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06364176",
            "orgStudyIdInfo": {
                "id": "STUDY00149479"
            },
            "organization": {
                "fullName": "University of Kansas Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.",
            "officialTitle": "Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis",
            "therapeuticArea": [
                "Other"
            ],
            "study": "targeting-inflammation-with-losartan-to-improve-response-to-modulator-therapy-in-cystic-fibrosis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-06",
            "studyFirstSubmitQcDate": "2024-04-10",
            "studyFirstPostDateStruct": {
                "date": "2024-04-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Kansas Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to test use of losartan in those with cystic fibrosis (CF) on modulator therapy. The main question it aims to answer is if treatment with losartan improves response of the CF transmembrane conductance regulator (CFTR) channel to modulator therapy.\n\nParticipants will be asked take losartan or placebo for twelve weeks and will have changes in sweat chloride levels measured as a marker of CFTR function.",
            "detailedDescription": "This is a randomized, placebo-controlled, parallel group clinical trial in those those with CF on elexacaftor/tezacaftor/ivacaftor to determine if treatment with losartan improves response to modulator therapy using sweat chloride as an marker of CFTR function."
        },
        "conditionsModule": {
            "conditions": [
                "Cystic Fibrosis"
            ],
            "keywords": [
                "losartan"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 42,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Losartan",
                    "type": "EXPERIMENTAL",
                    "description": "Losartan 25mg twice daily for one week followed by 50mg twice daily through week 12.",
                    "interventionNames": [
                        "Drug: Losartan"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo twice daily through week 12",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Losartan",
                    "description": "Treatment with losartan through week 12",
                    "armGroupLabels": [
                        "Losartan"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Treatment with placebo through week 12",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Sweat chloride",
                    "description": "Change in sweat chloride concentration",
                    "timeFrame": "Baseline through week 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Lung function - absolute",
                    "description": "Absolute change in percent predicted forced expiratory volume in one second (ppFEV1)",
                    "timeFrame": "Baseline through week 12"
                },
                {
                    "measure": "Lung function - relative",
                    "description": "Relative change in ppFEV1",
                    "timeFrame": "Baseline through week 12"
                },
                {
                    "measure": "Transforming growth factor (TGF)-beta1 - airway",
                    "description": "Change in nasal fluid levels of TGF-beta1",
                    "timeFrame": "Baseline through week 12"
                },
                {
                    "measure": "TGF-beta1 - systemic",
                    "description": "Change in plasma levels of TGF-beta1",
                    "timeFrame": "Baseline through week 12"
                },
                {
                    "measure": "Inflammatory mediators - airway",
                    "description": "Change in concentration nasal fluid levels of inflammatory mediators (interleukin-1beta, interleukin-8, tumor necrosis factor-alpha)",
                    "timeFrame": "Baseline through week 12"
                },
                {
                    "measure": "Inflammatory mediators - systemic",
                    "description": "Change in plasma levels of inflammatory mediators (interleukin-1beta, interleukin-8, tumor necrosis factor-alpha)",
                    "timeFrame": "Baseline through week 12"
                },
                {
                    "measure": "CFQ-R",
                    "description": "Change in CF questionnaire revised (CFQ-R); scale 0-100 with higher scores indicating better quality of life",
                    "timeFrame": "Baseline through week 12"
                },
                {
                    "measure": "Adverse events",
                    "description": "Cumulative incidence of adverse events",
                    "timeFrame": "Baseline through week 12"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Established diagnosis of cystic fibrosis\n* Age 12 years and older\n* Stable use of elexacaftor/tezacaftor/ivacaftor for 90 days prior to enrollment\n* Sweat chloride concentration 50 mmol/L or greater while on elexacaftor/tezacaftor/ivacaftor\n\nExclusion Criteria:\n\n* Prior lung transplant\n* BMI \\<18\n* CF pulmonary exacerbation requiring hospitalization or intravenous antibiotics in the preceding 30 days\n* Systemic corticosteroid or regular non-steroidal anti-inflammatory use in the preceding 30 days\n* Chronic use of angiotensin receptor blockers or angiotensin converting enzyme inhibitors\n* Concomitant use of medications known to interact with losartan, including aliskiren\n* Chronic renal insufficiency (creatinine clearance \\<45 ml/min)\n* Pregnancy or lactation\n* Inability or unwillingness to comply with approved contraceptive method during the study period (females of childbearing age)\n* In the opinion of the investigator any severe or acute or chronic condition or laboratory abnormality that may increase the risk associated with trial participation or make the participant inappropriate for enrollment\n* Participation in another interventional trial that, in the opinion of the investigator, has the potential to affect the primary outcome",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Heidi Hellwig",
                    "role": "CONTACT",
                    "phone": "9135886045",
                    "email": "hhellwig@kumc.edu"
                },
                {
                    "name": "Carolina Aguiar",
                    "role": "CONTACT",
                    "phone": "9139459295",
                    "email": "caguiar@kumc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Charles Bengtson, MD, MSc",
                    "affiliation": "University of Kansas Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Kansas Medical Center",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Charles Bengtson, MD, MSc",
                            "role": "CONTACT",
                            "phone": "913-588-6000"
                        },
                        {
                            "name": "Carolina Aguiar",
                            "role": "CONTACT",
                            "phone": "9139459295"
                        },
                        {
                            "name": "Matthias Salathe, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Andreas Schmid, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003550",
                    "term": "Cystic Fibrosis"
                },
                {
                    "id": "D000007249",
                    "term": "Inflammation"
                },
                {
                    "id": "D000005355",
                    "term": "Fibrosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6755",
                    "name": "Cystic Fibrosis",
                    "asFound": "Cystic Fibrosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8485",
                    "name": "Fibrosis",
                    "asFound": "Fibrosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10293",
                    "name": "Inflammation",
                    "asFound": "Inflammation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1710",
                    "name": "Cystic Fibrosis",
                    "asFound": "Cystic Fibrosis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019808",
                    "term": "Losartan"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000047228",
                    "term": "Angiotensin II Type 1 Receptor Blockers"
                },
                {
                    "id": "D000057911",
                    "term": "Angiotensin Receptor Antagonists"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21701",
                    "name": "Losartan",
                    "asFound": "Core",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4132",
                    "name": "Angiotensin II",
                    "relevance": "LOW"
                },
                {
                    "id": "M289354",
                    "name": "Giapreza",
                    "relevance": "LOW"
                },
                {
                    "id": "M4135",
                    "name": "Angiotensinogen",
                    "relevance": "LOW"
                },
                {
                    "id": "M25789",
                    "name": "Angiotensin II Type 1 Receptor Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M28916",
                    "name": "Angiotensin Receptor Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                }
            ]
        }
    },
    "hasResults": false
}